|
Figure 3
(a) Decay of apoferritin XEOL spectra as a function of absorbed dose and (b) the concomitant decay of diffracting power and luminescence (both overall and at the peak XEOL wavelength) of the same apoferritin crystal as a function of absorbed dose. XEOL decay is tracked both as a function of the normalized intensity at 494 nm (maximum of initial spectra; black squares) and the overall luminescence yield (as defined in §2.2.2 ![]() ![]() |